BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14529691)

  • 1. High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.
    Roth TM; Secord AA; Havrilesky LJ; Jones E; Clarke-Pearson DL
    Gynecol Oncol; 2003 Oct; 91(1):258-60. PubMed ID: 14529691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent cervical cancer.
    Leitao MM; Chi DS
    Curr Treat Options Oncol; 2002 Apr; 3(2):105-11. PubMed ID: 12057073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers.
    Gemignani ML; Alektiar KM; Leitao M; Mychalczak B; Chi D; Venkatraman E; Barakat RR; Curtin JP
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):687-94. PubMed ID: 11395237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
    Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
    Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
    Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
    Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
    Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative image-guided brachytherapy in early stage cervical cancers.
    Escande A; Mazeron R; Gouy S; Bentivegna E; Maroun P; Fahra G; Oberlander AS; Dumas I; Castelnau-Marchand P; Deutsch E; Morice P; Haie-Meder C; Chargari C
    Radiother Oncol; 2016 Sep; 120(3):455-459. PubMed ID: 27614680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
    Alektiar KM; Zelefsky MJ; Paty PB; Guillem J; Saltz LB; Cohen AM; Minsky BD
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):219-26. PubMed ID: 10924992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative radiotherapy in advanced, recurrent or metastatic malignancy.
    Calkins AR; Lester SG; Stehman FB; McCammon R; Hornback NB
    Indiana Med; 1985 Mar; 78(3):206-8. PubMed ID: 3920306
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraoperative high-dose-rate brachytherapy using dose painting technique: evaluation of safety and preliminary clinical outcomes.
    Morikawa LK; Zelefsky MJ; Cohen GN; Zaider M; Chiu J; Mathur N; Worman MF; Goodman KA
    Brachytherapy; 2013; 12(1):1-7. PubMed ID: 23167979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
    Terezakis S; Morikawa L; Wu A; Zhang Z; Shi W; Weiser MR; Paty PB; Guillem J; Temple L; Nash GM; Zelefsky MJ; Goodman KA
    Ann Surg Oncol; 2015 Jul; 22(7):2168-78. PubMed ID: 25631062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients.
    Mahé MA; Gérard JP; Dubois JB; Roussel A; Bussières E; Delannes M; Guillemin F; Schmitt T; Dargent D; Guillard Y; Martel P; Richaud P; Cuillière JC; De Ranieri J; Malissard L
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):21-6. PubMed ID: 12118553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.